StreetInsider.com News Articles

UnitedHealth Group (UNH) PT Raised to $512 at Bernstein SocGen Group

Tue, 21 Jul 2026 08:26:17 -0400

(Updated - July 21, 2026 8:26 AM EDT)

Bernstein SocGen Group analyst Lance Wilkes raised the price target on UnitedHealth Group (NYSE: UNH) to $512.00 (from $492.00) while maintaining an Outperform rating.

The analyst commented: "MA recovery on track, Optum Insights and non-MA UHC present upside; We remain Outperform on UNH and raise our price target to $512 representing 20% upside. We have updated our model which improved 2026 EPS by 6% and by around 0.5% for 2027 and beyond. We believe the UNH stock has reaped the initial bounce back of unusually low earnings and valuation, but continues to have attractive

UnitedHealth Group (UNH) PT Raised to $512 at Bernstein SocGen Group

Tue, 21 Jul 2026 08:26:17 -0400

(Updated - July 21, 2026 8:26 AM EDT)

Bernstein SocGen Group analyst Lance Wilkes raised the price target on UnitedHealth Group (NYSE: UNH) to $512.00 (from $492.00) while maintaining an Outperform rating.

UnitedHealth Group (UNH) PT Raised to $516 at JPMorgan

Tue, 21 Jul 2026 08:00:55 -0400

JPMorgan analyst Lisa Gill raised the price target on UnitedHealth Group (NYSE: UNH) to $516.00 (from $466.00) while maintaining a Overweight rating.

UnitedHealth Group (UNH) PT Raised to $493 at Mizuho

Mon, 20 Jul 2026 14:17:48 -0400

Mizuho analyst Ann Hynes raised the price target on UnitedHealth Group (NYSE: UNH) to $493.00 (from $470.00) while maintaining a Outperform rating.

The analyst comments "We are raising our 2026E-2028E adjusted EPS estimates by +10%, +17%, and +17%, supported by a solid EPS beat driven by better-than-expected MLR and strength in Optum Health operating income. Though UNH noted that Commercial recovery is now expected to take longer than previously anticipated, trends in Medicare Advantage (MA) are progressing better-than-initial expectations. On Optum, the three business segments were in-line or better than our expectations. The company also reiterated its long-term 13-16% earnings growth

UnitedHealth Group (UNH) PT Raised to $493 at Mizuho

Mon, 20 Jul 2026 14:17:48 -0400

Mizuho analyst Ann Hynes raised the price target on UnitedHealth Group (NYSE: UNH) to $493.00 (from $470.00) while maintaining a Outperform rating.

UnitedHealth Group (UNH) PT Raised to $512 at BofA Securities

Mon, 20 Jul 2026 13:41:07 -0400

BofA Securities analyst Kevin Fischbeck raised the price target on UnitedHealth Group (NYSE: UNH) to $512.00 (from $475.00) while maintaining a Buy rating.

The analyst comments "UNH beat consensus by 31% and raised guidance by 12% to $19.50-20.00 (+21% y/y). The upside was driven by a 180bp MLR beat largely in MA and Optum Health and was partially offset by continued investments in opex/AI to drive future EPS growth. UHC margins were up 220bp y/y and Optum up 160bp y/y, with Optum Health and Optum Insight both showing strong improvement y/y. Although there were some new wrinkles (commercial margin pressure and

UnitedHealth Group (UNH) PT Raised to $512 at BofA Securities

Mon, 20 Jul 2026 13:41:07 -0400

BofA Securities analyst Kevin Fischbeck raised the price target on UnitedHealth Group (NYSE: UNH) to $512.00 (from $475.00) while maintaining a Buy rating.

UnitedHealth Group (UNH) PT Raised to $441 at Barclays

Mon, 20 Jul 2026 04:56:48 -0400

Barclays analyst Andrew Mok raised the price target on UnitedHealth Group (NYSE: UNH) to $441.00 (from $429.00) while maintaining a Overweight rating.

UnitedHealth Group (UNH) PT Raised to $441 at Barclays

Mon, 20 Jul 2026 04:56:47 -0400

Barclays analyst Andrew Mok raised the price target on UnitedHealth Group (NYSE: UNH) to $441.00 (from $429.00) while maintaining a Overweight rating.

UnitedHealth Group (UNH) PT Raised to $490 at UBS

Fri, 17 Jul 2026 09:31:30 -0400

(Updated - July 17, 2026 9:31 AM EDT)

UBS analyst AJ Rice raised the price target on UnitedHealth Group (NYSE: UNH) to $490.00 (from $460.00) while maintaining a Buy rating.

The analyst commented, "The majority of the outperformance recorded in Q2 was related to Medicare Advantage (MA) - in the benefits business and in Optum Health. The PPD benefit that the company noted was spread across business lines (including OptumHealth). Regarding 2027 MA bids, the company indicated its bids included some benefit reductions and market exits, although much less compared to what was undertaken in the 2026 bid cycle. The company is not

UnitedHealth Group (UNH) PT Raised to $490 at UBS

Fri, 17 Jul 2026 09:31:30 -0400

(Updated - July 17, 2026 9:31 AM EDT)

UBS analyst AJ Rice raised the price target on UnitedHealth Group (NYSE: UNH) to $490.00 (from $460.00) while maintaining a Buy rating.

UnitedHealth Group (UNH) PT Raised to $529 at Morgan Stanley

Fri, 17 Jul 2026 08:17:32 -0400

Morgan Stanley analyst Erin Wright raised the price target on UnitedHealth Group (NYSE: UNH) to $529.00 (from $468.00) while maintaining a Overweight rating.

UnitedHealth Group (UNH) PT Raised to $500 at Oppenheimer

Fri, 17 Jul 2026 07:48:26 -0400

Oppenheimer analyst Michael Wiederhorn raised the price target on UnitedHealth Group (NYSE: UNH) to $500.00 (from $420.00) while maintaining a Outperform rating.

UnitedHealth Group (UNH) PT Raised to $500 at Truist Securities

Fri, 17 Jul 2026 07:02:26 -0400

Truist Securities analyst David MacDonald raised the price target on UnitedHealth Group (NYSE: UNH) to $500.00 (from $480.00) while maintaining a Buy rating.

UnitedHealth Group (UNH) PT Raised to $478 at RBC Capital

Fri, 17 Jul 2026 06:44:27 -0400

RBC Capital analyst Ben Hendrix raised the price target on UnitedHealth Group (NYSE: UNH) to $478.00 (from $463.00) while maintaining a Outperform rating.

UnitedHealth Group (UNH) PT Raised to $500 at KeyBanc

Fri, 17 Jul 2026 06:18:53 -0400

KeyBanc analyst Matthew Gillmor raised the price target on UnitedHealth Group (NYSE: UNH) to $500.00 (from $475.00) while maintaining a Overweight rating.

Baird Upgrades UnitedHealth Group (UNH) to Neutral

Thu, 16 Jul 2026 12:43:49 -0400

Baird analyst Michael Ha upgraded UnitedHealth Group (NYSE: UNH) from Underperform to Neutral with a price target of $453.00 (from $287.00).

For an analyst ratings summary and ratings history on UnitedHealth Group click here. For more ratings news on UnitedHealth Group click here.

Shares of UnitedHealth Group closed at $418.52 yesterday.

UnitedHealth rallies premarket while chip stocks retreat; TSMC earnings lift A

Thu, 16 Jul 2026 08:35:31 -0400

Investing.com -- U.S. stock index futures were mixed on Thursday as investors weighed lingering Middle East tensions, and focused on corporate earnings and further signs that U.S. inflationary pressures are easing.

By 08:10 ET, S&P 500 futures edged down 0.3%, Nasdaq 100 futures fell 1%, while Dow Jones futures rose 0.1%.

Semiconductor stocks were under pressure despite another blockbuster quarter from Taiwan Semiconductor Manufacturing Co., whose second-quarter profit surged 77% year-on-year to a record level, comfortably beating Wall Street expectations.

The world’s largest contract chipmaker posted earnings per share of $4.31, ahead of estimates for $3.80, but shares fell about 4% in premarket

UnitedHealth rallies premarket while chip stocks retreat; TSMC earnings lift A

Thu, 16 Jul 2026 08:35:31 -0400

By 08:10 ET, S&P 500 futures edged down 0.3%, Nasdaq 100 futures fell 1%, while Dow Jones futures rose 0.1%.

The world’s largest contract chipmaker posted earnings per share of $4.31, ahead of estimates for $3.80, but shares fell about 4% in premarket

BofA Securities on UnitedHealth Group (UNH): 'Q2/guidance raise even better than bulls expected'

Thu, 16 Jul 2026 08:12:18 -0400

BofA Securities analyst Kevin Fischbeck reiterated a Buy rating and $475.00 price target on UnitedHealth Group (NYSE: UNH).

The analyst comments "UNH reported Q2 EPS of $6.38, 31% above consensus, and raised 2026 EPS by $1.50 from $18.25 (+12% y/y) to $19.50-20.00 (+21% y/y). The upside was driven by a 180bp MLR beat (86.7% vs cons. of 88.5%) and partially offset by continued investments in opex/AI to drive future EPS growth as UNH sets up for continued momentum in EPS growth in 2027+. UHC margins were up 220bp y/y and Optum up 160bp y/y, with Optum Health and Optum Insight both

UnitedHealth Group (UNH) PT Raised to $477 at Piper Sandler, 'We would be buyers'

Thu, 16 Jul 2026 07:57:00 -0400

Piper Sandler analyst Jessica Tassan raised the price target on UnitedHealth Group (NYSE: UNH) to $477.00 while maintaining a Overweight rating.

The analyst comments "We would be buyers of UNH on continued execution. Huge 2Q26 beats at UHC and Optum Health drove an upward revision to the CY26 guide so large we would call it a reset. A few highlights on the reset CY26 guidance. UNH raised CY26 adjusted EPS guide to $19.50-$20.00. This is up $1.50 vs. prior >$18.25 guide, and implies 20.80% y/y adjusted EPS growth at the midpoint. CY26 MCR range is now 87.85-88.35%, down from prior CY26

UnitedHealth Group (UNH) PT Raised to $477 at Piper Sandler, 'We would be buyers'

Thu, 16 Jul 2026 07:57:00 -0400

Piper Sandler analyst Jessica Tassan raised the price target on UnitedHealth Group (NYSE: UNH) to $477.00 while maintaining a Overweight rating.

UnitedHealth shares surge on strong earnings beat and guidance

Thu, 16 Jul 2026 06:43:18 -0400

Investing.com -- UnitedHealth Group (NYSE:UNH) reported second quarter results that exceeded analyst expectations across earnings, revenue and guidance, sending shares up 7% premarket as investors responded positively to the healthcare giant's improved outlook.

The company posted adjusted earnings of $6.38 per share, beating the analyst consensus of $4.85 by $1.53. Revenue reached $112.0 billion, surpassing the $110.76 billion estimate and up slightly from $111.6 billion in the prior year quarter.

UnitedHealth raised its full-year 2026 adjusted earnings guidance to $19.50 to $20.00 per share, with a midpoint of $19.75 that exceeds the analyst consensus of $18.48.

"Our results and outlook

UnitedHealth shares surge on strong earnings beat and guidance

Thu, 16 Jul 2026 06:43:18 -0400

UnitedHealth raised its full-year 2026 adjusted earnings guidance to $19.50 to $20.00 per share, with a midpoint of $19.75 that exceeds the analyst consensus of $18.48.

"Our results and outlook

UnitedHealth shares surge on strong earnings beat and guidance

Thu, 16 Jul 2026 06:43:18 -0400

UnitedHealth raised its full-year 2026 adjusted earnings guidance to $19.50 to $20.00 per share, with a midpoint of $19.75 that exceeds the analyst consensus of $18.48.

"Our results and outlook